tiprankstipranks
Inhibrx Biosciences, Inc. (INBX)
NASDAQ:INBX
US Market
INBX
Inhibrx Biosciences Inc
RESEARCH TOOLSreports
Want to see INBX full AI Analyst Report?

Inhibrx Biosciences Inc (INBX) Income Statement

67 Followers

Inhibrx Biosciences Inc Income Statement

Last quarter (Q4 2025), Inhibrx Biosciences Inc's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Inhibrx Biosciences Inc's net income was $-32.83M. See Inhibrx Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.30M$ 200.00K$ 1.80M$ 2.19M$ 7.13M
Gross Profit
$ -1.18M$ -2.08M$ 609.00K$ -107.99M$ 4.44M
Operating Expenses
$ 133.84M$ 329.36M$ 219.83M$ 21.12M$ 12.34M
Depreciation and Amortization
$ 2.48M$ 2.29M$ 1.19M$ 1.23M$ 1.20M
EBITDA
$ -132.54M$ 1.70B$ -206.69M$ -125.82M$ -75.37M
Operating Income
$ -135.03M$ -331.45M$ -219.22M$ -129.12M$ -76.56M
Other Income/Expenses
$ -5.03M$ 2.02B$ -20.50M$ -16.11M$ -5.20M
Pretax Income
$ -140.05M$ 1.69B$ -239.72M$ -145.22M$ -81.77M
Net Income
$ -140.06M$ 1.69B$ -241.36M$ -145.23M$ -81.77M
Per Share Metrics
Basic EPS
$ -9.04$ 116.58$ -5.12$ -3.62$ -2.15
Diluted EPS
$ -9.04$ 116.58$ -5.12$ -3.62$ -2.15
Weighted Average Shares Outstanding
 15.49M 14.48M 47.13M 40.11M 38.01M
Weighted Average Shares Outstanding (Diluted)
 15.49M 14.48M 47.13M 40.11M 38.01M
Currency in USD

Inhibrx Biosciences Inc Earnings and Revenue History